Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
SVM$8.18-0.16(-1.92%)SILVERCORP REPORTS ADJUSTED NET INCOME OF $18.4 MILLION, $0.08 PER SHARE, AND CASH FLOW FROM OPERATING ACTIVITIES OF $62.7 MILLION FOR Q2 FISCAL 20275:06:04 PM ETNET$279.00+34.49(+14.11%)Cloudflare Q3 revenue beats estimates on AI platform demand5:05:25 PM ETTMO$680.00-26.16(-3.70%)Thermo Fisher Scientific Announces Quarterly Dividend5:00:04 PM ETWPM$131.25-0.25(-0.19%)Wheaton Precious Metals Announces Third Quarter 2026 Results and Record Year-to-Date Production, Sales Volume, Revenue, Earnings and Cash Flow5:00:00 PM ETTSX:SAP$41.620.00(0.00%)Saputo Reports Financial Results for the Second Quarter of Fiscal 2027 Ended September 30, 20265:00:00 PM ETNET$279.00+34.49(+14.11%)Cloudflare Stock Surges on Lifted Full-Year Outlook, Third-Quarter Revenue Growth5:00:00 PM ETMNST$45.09-3.66(-7.51%)Monster Beverage Q3 sales beat estimates as marketing investments boost results4:56:44 PM ETEOG$144.89-2.17(-1.48%)UPDATE 2-US shale producer EOG Resources beats profit estimates on higher crude prices4:55:18 PM ETANTUPDATE 1-A&O Shearman's $1.1 billion AI plan builds on law firms' tech investments4:51:58 PM ETDNA$9.76-1.89(-16.21%)Ginkgo Bioworks Q3 revenue falls compared to last year4:51:51 PM ETABX$8.83-0.22(-2.43%)Abacus Global Management Q3 revenue, adjusted EBITDA beat estimates4:51:39 PM ETPRTA$7.89-0.50(-5.96%)Prothena Q3 net loss narrows on lower costs4:51:15 PM ETLRCX$193.04+7.84(+4.23%)BUZZ-Chip firm Lam Research rises after announcing $25 bln stock buyback4:50:28 PM ETEOG$144.89-2.17(-1.48%)EOG Resources Q3 revenue ease past estimates amid strong price realizations4:49:39 PM ETNVDA$181.98+0.38(+0.21%)Stock Market Today, Nov. 5: Nvidia Slides on AI Chip Selloff as Election Uncertainty Weighs4:49:38 PM ETCVS$81.01+1.05(+1.31%)AM Best Places Credit Ratings of CVS Health Corporation’s Aetna Inc. Subsidiaries Under Review with Developing Implications4:49:03 PM ETPTGX$135.26-8.11(-5.66%)Protagonist Therapeutics Q3 revenue surges on Takeda payments4:48:48 PM ETVERX$17.47+1.55(+9.74%)Prediction: Vertex Pharmaceuticals Will Be 1 of the Best Biotech Stocks to Own Over the Next 5 Years4:47:00 PM ETETOLF$1.22-0.02(-1.61%)Enterprise Prices $1.5 Billion Aggregate Principal Amount of Senior Notes4:47:00 PM ETEPD$36.72+0.10(+0.27%)Enterprise Prices $1.5 Billion Aggregate Principal Amount of Senior Notes4:47:00 PM ETSPG$225.88-2.63(-1.15%)Simon Property Q3 Real Estate FFO per share rises; 2026 outlook raised4:46:33 PM ETEOG$144.89-2.17(-1.48%)UPDATE 1-US shale producer EOG Resources beats quarterly profit estimates on higher crude prices4:45:57 PM ETWFC$84.51-0.29(-0.34%)Wells Fargo & Company (WFC) Presents at BancAnalysts Association of Boston Conference 2026 Transcript4:45:03 PM ETMNST$45.09-3.66(-7.51%)Monster Beverage Profit Rises as International Sales Jump4:44:00 PM ET

DNA · NYSE

Ginkgo Bioworks Holdings, Inc.

$9.76 -1.90 (-16.30%)

Company overview

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop the ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Sector
Healthcare
Industry
Biotechnology
Exchange
NYSE
Market cap
$657M
Employees
834
Headquarters
Boston, MA
Website
ginkgobioworks.com
CEO
Jason Kelly
Listed
April 19, 2021
P/E
-1.82
Dividend yield
0.00%

Company financials

Revenue
$141M
Gross profit
$106M
Operating income
-$298M
EBITDA
-$206M
Net income
-$304M
EPS
-$5.37
Total assets
$1B
Total debt
$411M
Gross margin
74.97%
Net margin
-215.41%
Earnings yield
-55.02%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

No geographic segmentation.

Showing FY 2025

Price chart

6.009.1712.3415.5218.69
DNA 1D NYSE O10.90H11.77L10.76C11.65+0.89 (+8.27%)Vol2.69M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
View
Ticker Type Headline Source Published
DNAGinkgo Bioworks Holdings, Inc. Stock news Ginkgo Bioworks Q3 revenue falls compared to last year Reuters
DNAGinkgo Bioworks Holdings, Inc. Stock news BRIEF-Ginkgo Bioworks Q3 Net Income USD -40.984 Million Reuters
DNAGinkgo Bioworks Holdings, Inc. Press release Ginkgo Bioworks Reports Third Quarter 2026 Results; Signs First Autonomous Lab Sale to a Top-Tier Pharma Company Novo Business Wire
DNAGinkgo Bioworks Holdings, Inc. Stock news Ginkgo Bioworks Holdings, Inc. (DNA) Suffers a Larger Drop Than the General Market: Key Insights Zacks Investment Research
DNAGinkgo Bioworks Holdings, Inc. Stock news Hugging Face is launching a new AI model that lets scientists 'chat with DNA' Business Insider
DNAGinkgo Bioworks Holdings, Inc. Stock news Here's Why Ginkgo Bioworks Holdings, Inc. (DNA) Fell More Than Broader Market Zacks Investment Research
DNAGinkgo Bioworks Holdings, Inc. Press release Ginkgo Bioworks to Provide Autonomous Lab Access to NSF X-Labs Researchers, Contributing Cloud Lab Time and Protein Testing Services to $1.5 Billion Breakthrough Science Program Business Wire
DNAGinkgo Bioworks Holdings, Inc. Press release Oct 08, 2026, 15:22 ET Araceli Biosciences et Ginkgo Bioworks intègrent l'imagerie cellulaire à grande échelle à la boucle laboratoire de Nebula Araceli Biosciences et Ginkgo Bioworks (NYSE : DNA) annoncent aujourd'hui l'intégration de l'in. PR Newswire
DNAGinkgo Bioworks Holdings, Inc. Stock news Araceli Biosciences y Ginkgo Bioworks incorporan la obtención de imágenes celulares al laboratorio de Nebula PRNewsWire
DNAGinkgo Bioworks Holdings, Inc. Press release Araceli Biosciences and Ginkgo Bioworks Bring Cellular Imaging at Scale to Nebula's Lab-in-the-Loop PRNewsWire
DNAGinkgo Bioworks Holdings, Inc. Press release Oct 08, 2026, 06:00 ET Araceli Biosciences and Ginkgo Bioworks Bring Cellular Imaging at Scale to Nebula's Lab-in-the-Loop Araceli Biosciences and Ginkgo Bioworks (NYSE: DNA) today announced the integration of Araceli's Endeavor® high-conte. PR Newswire
DNAGinkgo Bioworks Holdings, Inc. Stock news Ginkgo Bioworks Holdings, Inc. (DNA) Falls More Steeply Than Broader Market: What Investors Need to Know Zacks Investment Research
DNAGinkgo Bioworks Holdings, Inc. Stock news Apogee Enterprises Posts Upbeat Q2 Earnings, Joins Constellation Energy, Freshworks And Other Big Stocks Moving Higher On Tuesday Benzinga
DNAGinkgo Bioworks Holdings, Inc. Stock news This Small-Cap Stock Announced a Deal With Eli Lilly. Then Its Shares Doubled The Motley Fool
DNAGinkgo Bioworks Holdings, Inc. Stock news Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know Zacks Investment Research
DNAGinkgo Bioworks Holdings, Inc. Press release Ginkgo Datapoints and Apheris Welcome AbbVie, argenx, Lundbeck, and Takeda as Founding Members of the Antibody Developability Consortium Business Wire
P Stock news Everpure, Fervo Energy, Charles River Laboratories And Other Big Stocks Moving Higher On Thursday Benzinga
DNAGinkgo Bioworks Holdings, Inc. Press release Kala Bio and Virotek Sign Letter of Intent with U.S. DNA GlobeNewswire
DNAGinkgo Bioworks Holdings, Inc. Stock news Ginkgo Bioworks Holdings, Inc. (DNA) Sees a More Significant Dip Than Broader Market: Some Facts to Know Zacks Investment Research
DNAGinkgo Bioworks Holdings, Inc. Stock news Ginkgo Bioworks (DNA) Surges 11.1%: Is This an Indication of Further Gains? Zacks Investment Research
See more
FAQ

Questions about Ginkgo Bioworks Holdings, Inc.

What does Ginkgo Bioworks Holdings, Inc. do?
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop the ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
What is DNA's market cap?
Ginkgo Bioworks Holdings, Inc. (DNA) is a listed stock with a live quote. The latest market cap on this page is $657M.
Where is Ginkgo Bioworks Holdings, Inc. headquartered?
Ginkgo Bioworks Holdings, Inc. is headquartered in Boston, MA.
How do I get DNA news from the API?
Call GET /v1/news?tickers=DNA. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does DNA news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for DNA, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the DNA price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs